don't worry my friend, I've seen that the price has stabled at 0.175-0.18 That's the bottom, now is the time to get in. Some more our abang awang have dispose some of his serba's share. What he's gonna do with those money? Collect some more AIMFLEX share?
-The order book as of the end of May is 28m. -In terms of cooperation and expansion, this year there are some customers from new fields such as semiconductors and medical. Also continue to get orders from e&e. -There are four new products in R&D. -The epidemic has caused longer lead time and higher operating costs for products-Customer delays in launching new products will affect the group's revenue-Q1 is due to factory outages, part of the outsourcing and subsequent need to catch up with production capacity, resulting in cost overrun, product mix The change is also one of the factors. New products will increase operational efficiency and reduce lead time. -The tax pioneer status of one of the subsidiaries will be expired in 2021, and the extension is under discussion. -Most of the expansion is still in the stage of vendor qualification, and it is not expected that there will be much contribution this year, especially in the recent automotive market. More substantial developments will not begin to show until early 2022. -The Group's products mainly provide products and services to customers before launching new products. If customers reduce the launch of new products, their revenue will be affected. -The biggest problem with revenue and net profit is that it is difficult to close deal during the epidemic, but the current 28m order is expected to be able to achieve better financial performance. -The new design and development centre is currently on hold because the production capacity is still sufficient to meet orders. -The overall situation is still optimistic. It can be seen that the market demand for the company's products will become higher and higher in the future. -The summary is that there will be no surprises or frights in 2021. The future development is very dependent on competitiveness, and there will be major and substantial changes in 2022. Since November 2019, the average order book is between 17.93m and 28.71m, which means that the current order book is at a historical high point. How to control costs and increase profit is the biggest challenge.
i hope google translator got it right for our non-chinese reader
their major customer is dyson, and almost all test equipment supply by them. mr awang spend so much money to aquired it, and bring it in into O&G industry. you all can imagine how many test equipment going to use in O&G sector. it is a very potential company, just because of pandemic temporary halt it progress.
Why O&G need test equipment. Test the oil when drill up. No good stop, go another place drill again and test. OR after weilding big pipe, test weather is it total weild evenlly. Just queress.
O&G is not necessarily be upstream O&G, it could be downstream O&G. There are alot of sampling and testing in O&G sector, purpose is to verify content of sample for purify, contamination, mixture, production quality etc. Different test at different stage for different purposes.
It does have an effect { any counter link indirectly with Serba } case in point is KPower, SCIB having a common shareholder.aimflwx is link with the other shareholder { Awang }
Erm, you guys could check it on the annual report 2020 "List of Thirty Largest Shareholders", is not a recent news that the have that much stakes in Aimflex since 2019.
once this quarter result shows better result compare to past..it will start moving...once the automotive sector back to normal..AIMFLEX is next QES in making...
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
8dragon
2,223 posts
Posted by 8dragon > 2021-06-11 15:32 | Report Abuse
This counter under Awang has no future....